Biography of Bernhard kuster

Bernhard Kuster is a chemist by training and obtained is PhD in Biochemistry from the University of Oxford. He did a PostDoc funded by an EMBO long-term fellowship at the EMBL in Heidelberg and the University of Southern Denmark in Odense. After seven years as Vice President Analytical Sciences and Informatics at the biotech firm Cellzome (now GSK), he became Full Professor of Proteomics at the Technical University of Munich (TUM) in 2007. He currently is also the Director of the Bavarian Biomolecular Mass Spectrometry Center, a Fellow of the TUM Institute for Advanced Study and a member of the German National Academy of Science Leopoldina.

Bernhard’s research focuses on proteomics and its application to chemical and cancer biology. He is particularly interested in understanding how therapeutic drugs impact cellular signaling pathways to understand their often multiple modes of action. Bernhard has received an ERC Advanced Grant in 2019 aiming to integrate proteomics into precision medicine. He has published more than 250 papers on proteomics and bioinformatics and received a number of awards, including the “Discovery in Proteomic Sciences Award” of the Human Proteome Organisation (HUPO) for mapping out a draft of the human proteome and the HUPO “Distinguished Achievement Proteomic Sciences Award” for his work on chemical proteomics. Bernhard has co-founded two start-up companies that operate in the area of proteomics and artificial intelligence.